Elliptic Laboratories ASA (OSL:ELABS) Notes Receivable: kr0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:ELABS Elliptic Laboratories ASA OSL:ELABS
73 GF Score
Price kr2.42
GF Value kr13.92
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Elliptic Laboratories ASA Notes Receivable?

Elliptic Laboratories ASA OSL:ELABS 73 Notes Receivable is kr0.0 Mil as of Mar. 2026. GuruFocus rates OSL:ELABS with a GF Score™ of 73/100 and a GF Value™ of kr13.92 (Possible Value Trap). The stock has 3 warning signs investors should review.

Elliptic Laboratories ASA's Notes Receivable for the quarter that ended in Mar. 2026 was kr0.0 Mil.

Elliptic Laboratories ASA Notes Receivable Related Terms

Elliptic Laboratories ASA Notes Receivable Historical Data

* Premium members only.

The historical data trend for Elliptic Laboratories ASA's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elliptic Laboratories ASA Notes Receivable Chart

Elliptic Laboratories ASA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Elliptic Laboratories ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSL:ELABS
73GF Score
Elliptic Laboratories ASA OSL:ELABS
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elliptic Laboratories ASA Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.0 Mil mean?
Elliptic Laboratories ASA (OSL:ELABS) has a Notes Receivable of kr0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Elliptic Laboratories ASA and its competitors.
Is Elliptic Laboratories ASA's Notes Receivable too high?
Elliptic Laboratories ASA's current Notes Receivable is kr0.0 Mil. Overall, Elliptic Laboratories ASA has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Elliptic Laboratories ASA's Notes Receivable compare to MSFT and ORCL?
Elliptic Laboratories ASA's Notes Receivable of kr0.0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Software company?
A good Notes Receivable depends on the Software industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Elliptic Laboratories ASA and its competitors. Elliptic Laboratories ASA's current Notes Receivable is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elliptic Laboratories ASA stock overvalued right now?
Based on GuruFocus' analysis, Elliptic Laboratories ASA (OSL:ELABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr13.92, compared to a current price of kr2.42 — trading 82.6% below its estimated fair value. The current Notes Receivable is kr0.0 Mil. Elliptic Laboratories ASA's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Elliptic Laboratories ASA (OSL:ELABS), the current Notes Receivable is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elliptic Laboratories ASA (OSL:ELABS) Overvalued in 2026?

Based on GuruFocus' analysis, Elliptic Laboratories ASA stock appears to be undervalued. The current stock price of kr2.42 is trading 82.6% below its estimated GF Value™ of kr13.92. GuruFocus considers Elliptic Laboratories ASA to be Possible Value Trap.

Key valuation signals for OSL:ELABS:

  • Notes Receivable: kr0.0 Mil
  • GF Value™: kr13.92 vs. price of kr2.42 (82.6% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the OSL:ELABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elliptic Laboratories ASA Business Description

Other Exchanges ELABSo:SwedenEIP:Germany
Address Hausmannsgate 21, Oslo, NOR, 0182
Elliptic Laboratories ASA develops and sells technical solutions that enable the interaction and information exchanges between individuals and technical devices, based on ultrasound software technology. Such devices include mobile phones, IoT devices, and other devices that could deploy the group's software technology to enhance the user experience. Its patented artificial intelligence (AI) software platform combines ultrasound and sensor fusion algorithms to deliver intuitive proximity, presence, and gesture sensing experiences. Its scalable AI Virtual Smart Sensor Platform creates software-only sensors that are sustainable, eco-friendly, and already deployed in hundreds of millions of devices around the world.
73GF Score

Get the complete analysis for OSL:ELABS

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.42
Price
kr13.92
GF Value